Skip to main content
TipRanks
Go Ultimate75% OFF

Hang Lung Group (0010) AI Stock Analysis

25 Followers
HK:0010

Hang Lung Group

(HKEX:0010)

Select Model
Rating:61Neutral
Price Target:HKD 13.00▲(11.40% Upside)
Action:reiterated
Date:11/05/26

The overall score of 61 reflects a company with a strong financial foundation and attractive valuation, balanced by stagnant growth and operational headwinds. The most significant positive factors are the high dividend yield (6.99%) and low P/E ratio (11.84), which are supported by robust cash flow generation. The resumption of a cash dividend, as highlighted in the earnings call, reinforces this strength. However, these are offset by a low return on equity (1.39%) and declining profitability, which limit the company's ability to generate shareholder value. Technicals are neutral, providing no strong directional catalyst.

Positive Factors
Recurring leasing growthGrowth in the core leasing business supports recurring earnings and demonstrates continued monetisation of the group’s investment-property portfolio. A larger recurring profit base can improve resilience versus development timing and provide a durable foundation for cash generation.
Negative Factors
Mainland office weaknessPersistent competition and tenant incentives can weaken office occupancy economics, rental income and margins across the Mainland portfolio. If these conditions continue, they may offset stronger retail performance and reduce the recurring earnings contribution from offices.

Hang Lung Group (0010) vs. iShares MSCI Hong Kong ETF (EWH)

-25%-20%-15%-10%-5%0%5%10%15%HK:0010-21.07%EWH+4.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 2.11B
Dividend Yield
7.37%
Average Volume (3M)
758.67K
Price to Earnings (P/E)
11.2
Beta (1Y)
0.70
Revenue Growth
9.19%
EPS Growth
-0.21%
Country
Hong Kong
Employees
4,595
Sector
Real Estate
Sector Strength
65
Industry
Real Estate - Development

Hang Lung Group Business Overview & Revenue Model

Company Description

Hang Lung Group Limited, established in 1960 and based in Central, Hong Kong, functions as an investment holding company with a primary focus on real estate development across Hong Kong and mainland China. Its operations are divided into two main div...

How the Company Makes Money

Hang Lung Group makes money primarily through its property-related activities. Key revenue and earnings sources include: (1) Property investment income: recurring rental revenue generated from leasing space in its investment properties (e.g., retail,...

Hang Lung Group Earnings Call Summary

Earnings Call Date:Jul 31, 2026(Q2-2026)|% Change Since:-14.81%|Next Earnings Date:Jan 28, 2027
Earnings Call SentimentPositive

The call presented a balanced but predominantly constructive picture: recurring leasing and retail operations showed healthy momentum (leasing revenue +5%, Mainland mall sales and customer metrics strong, membership growth robust), balance sheet metrics improved (net gearing down, cost of borrowing lower) and Westlake 66 and other developments delivered promising early results. Offsetting these positives were one-off accounting provisions (notably a HK$124m Wuhan SA provision) that depressed headline results, notable softness in Mainland office revenue (-12%) and temporary margin pressure from new openings and lower capitalization. Management emphasised cautious optimism, prudent accounting and a focus on quality leasing and customer engagement, with dividend resumption and ESG progress as supporting signals. Net effect: more positives than negatives but with clear near-term headwinds in offices and some non-cash provisioning risks.

Positive Updates

Core leasing revenue growth
Leasing revenue increased by 5% with operating profit up 4%; core leasing business remains the main earnings driver and contributed the majority of recurring profit.

Negative Updates

One-off provision in Wuhan serviced apartment
A non-cash provision of approximately HK$124 million was taken for the Wuhan serviced-apartment (DP/SA) project, which materially skewed headline results and contributed to a reported negative 'optics' (management cited an apparent ~10% headline decline driven by this item).

Company Guidance

Management's guidance was cautiously constructive: they expect Mainland tenant sales to remain positive into H2 (management cited H1 retail trends of Q1 +24%, Q2 +9%, H1 about +6% and guided H2 to be “high single‑digit”), target Westlake 66 mall to break even by Q4 2026 with mall metrics already strong (May Golden Week avg ~120,000 daily footfall; stabilized 40k–50k; end‑June occupancy 89% with 98% commitment; 250 stores, ~100 first‑to‑market) and expect Westlake office occupancy to reach ~70% by end‑2027; key openings include Curio Wuxi (~Sept 2026), Mandarin Oriental (Q1 2027) and Kimpton Xujiahui (H2 2027), and Phase‑2 will expand GFA to ~150,000 sqm. On finances they flagged continued strength and flexibility: net gearing ~31.6%, average borrowing cost ~3.7%, ~50% of debt RMB‑denominated, average debt maturity ~3 years, ~HK$18bn unused facilities, 69% of debt maturing in >2 years, and finance‑cost capitalization expected to fall to ~30% for 2026. The Board resumed a cash dividend (no scrip this round), intends a progressive approach and signaled limited near‑term risk of a cut given current payout levels and balance‑sheet buffers.

Hang Lung Group Financial Statement Overview

Summary

Financial performance is mixed. Cash flow is a relative strength, with operating cash flow of HKD 4.3B and a healthy free cash flow to net income ratio of 0.93. The balance sheet is solid with low leverage (D/E 0.56), but return on equity is very low at 1.39%. The income statement shows stable but stagnant revenue and declining net profit margins to 13.2%, weighing on the overall score.

Income Statement

55Neutral

Balance Sheet

50Neutral

Cash Flow

63Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.56B10.42B11.76B11.01B10.94B10.93B
Gross Profit6.69B6.69B6.83B7.92B7.68B7.82B
EBITDA5.94B6.31B5.21B7.20B7.08B7.26B
Net Income1.42B1.37B1.61B2.81B2.72B2.59B
Balance Sheet
Total Assets241.72B236.23B234.97B231.45B226.54B238.03B
Cash, Cash Equivalents and Short-Term Investments7.03B6.79B10.82B6.34B5.79B9.14B
Total Debt55.90B55.37B58.06B50.97B46.25B46.22B
Total Liabilities82.39B80.97B82.28B76.54B71.33B73.54B
Stockholders Equity102.30B98.88B95.78B94.36B92.82B95.84B
Cash Flow
Free Cash Flow1.02B4.02B5.04B3.91B378.00M-1.14B
Operating Cash Flow1.27B4.32B5.21B4.02B3.10B1.74B
Investing Cash Flow257.00M-2.31B-3.07B-2.85B-3.20B-1.44B
Financing Cash Flow1.95B-6.13B2.38B-566.00M-4.25B1.82B

Hang Lung Group Technical Analysis

Technical Analysis SentimentNegative
Last Price11.67

Price Trends

50DMA12.16Negative
100DMA12.54Negative
200DMA13.73Negative

Market Momentum

MACD-0.09Positive
RSI32.67Neutral
STOCH10.57Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0010, the sentiment is Negative. The current price of 11.67 is below the 20-day moving average (MA) of 12.12, below the 50-day MA of 12.16, and below the 200-day MA of 13.73, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 32.67 is Neutral, neither overbought nor oversold. The STOCH value of 10.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0010.

Hang Lung Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

HK:0010 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
HK:0010HK:001061NeutralHKD 16.12B11.221.41%7.37%9.19%-0.21%
HK:0041HK:004158NeutralHKD 10.40B-38.39-0.52%7.74%74.94%84.97%
HK:0012HK:001252NeutralHKD 139.04B20.432.11%4.47%45.52%13.35%
HK:0978HK:097841NeutralHKD 1.09B-0.42-39.42%―25.82%-27.10%
HK:0017HK:001740UnderperformHKD 5.66B-0.30-16.35%―9.77%-72.68%
HK:3377HK:337738UnderperformHKD 331.14M-0.02239.84%―-4.40%-61.12%

* Real Estate Sector Average

Performance Comparison

-50%0%50%HK:0010HK:0041HK:0012HK:0017HK:3377HK:0978Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:0010 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0010Hang Lung Group 11.67-3.29-21.97%
HK:0041Great Eagle Holdings 13.820.382.81%
HK:0012Henderson Land Development Co 28.20-0.25-0.89%
HK:0017New World Development Co. Ltd.2.30-4.85-67.83%
HK:3377Sino-Ocean Group Holding 0.03-0.08-75.47%
HK:0978China Merchants Land Limited0.22-0.07-24.14%

Hang Lung Group Corporate Events

Hang Lung Group Sets New Board and Committee Structure from October 2026

Sep 30, 2026

Hang Lung Group Limited has announced an updated composition of its board of directors, effective October 1, 2026, confirming Adriel Chan as chair, Leo Tak Lun Tsoi as chief executive officer, and Kenneth Ka Kui Chiu as chief financial officer among...

Hang Lung Group Sets Out Board and Committee Structure

Sep 7, 2026

Hang Lung Group Limited has announced the current composition of its board of directors, led by Chair Adriel Chan and Chief Executive Officer Weber Wai Pak Lo, with Leo Tak Lun Tsoi named Chief Executive Officer Designate and Kenneth Ka Kui Chiu serv...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026